Outsmarting Antigen Escape: Next‐Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70252 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Amr Ali Mohamed Abdelgawwad El-Sehrawy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Diabetes, Endocrinology and Metabolism, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Tumor Escape. Die Arbeit nennt 194 Literaturangaben.
Abstract (Originalsprache)
Chimeric antigen receptor (CAR) T‐cell therapy has revolutionized the treatment of hematologic malignancies, producing unprecedented clinical responses in relapsed or refractory B‐cell acute lymphoblastic leukemia (B‐ALL), diffuse large B‐cell lymphoma, and multiple myeloma. Despite these advances, durable remission remains limited by disease relapse, with antigen escape emerging as one of the principal mechanisms of therapeutic resistance. This review comprehensively summarizes the biologic mechanisms underlying antigen escape and highlights emerging engineering strategies designed to overcome immune evasion and improve long‐term CAR T‐cell efficacy. We discuss both irreversible and reversible resistance pathways, including genetic alterations, alternative splicing, lineage plasticity, trogocytosis, epigenetic repression, and tumor microenvironment‐mediated antigen modulation. Particular emphasis is placed on clinically relevant examples such as CD19 loss in B‐ALL and BCMA dysregulation in multiple myeloma. The review further examines next‐generation approaches developed to prevent antigen‐negative relapse, including dual‐ and multi‐target CAR constructs, logic‐gated systems, pharmacologic enhancement of antigen density, epitope spreading, and TCR‐mimic CAR platforms targeting intracellular antigens. In addition, we evaluate the major translational and biologic challenges associated with these advanced strategies, including structural complexity, manufacturing barriers, toxicity control, tumor heterogeneity, and limited long‐term clinical validation. Finally, we discuss future perspectives involving single‐cell and multi‐omic technologies, computational modeling, and universal modular CAR systems that may enable the development of safer, more adaptable, and precision‐guided cellular immunotherapies for hematologic malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine, Diabetes, Endocrinology and Metabolism, Mansoura University, Mansoura, Egypt.
- Department of Biopharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Al-Ahliyya Amman University, Aman, Jordan.
- Department of Urology, Samarkand State Medical University, Samarkand, Uzbekistan.
- Department of Basic Medical Sciences, Termez University of Economics and Service, Termez, Uzbekistan.
- Department of Biological Sciences, National Pedagogical University of Uzbekistan Named After Nizami, Tashkent, Uzbekistan.
- Department of Microbiology, IMS and SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, Odisha, India.
ORCID-Profile: Amr Ali Mohamed Abdelgawwad El-Sehrawy
Zitieren
APA
Abdelgawwad El-Sehrawy, A. A. M., Alfreahat, I., Bobokulov, N., Tursunov, Q., Shakhmurova, G., Panigrahi, R., Hashem, R. M., & Bainsal, N. (2026). Outsmarting Antigen Escape: Next‐Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies. European Journal of Haematology. https://doi.org/10.1111/ejh.70252
Vancouver
Abdelgawwad El-Sehrawy AAM, Alfreahat I, Bobokulov N, Tursunov Q, Shakhmurova G, Panigrahi R, et al. Outsmarting Antigen Escape: Next‐Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies. European Journal of Haematology. 2026. doi:10.1111/ejh.70252
BibTeX
@article{AbdelgawwadElSehrawy2026,
author = {Abdelgawwad El-Sehrawy, Amr Ali Mohamed and Alfreahat, Islam and Bobokulov, Nurillo and Tursunov, Quvonch and Shakhmurova, Gulnora and Panigrahi, Rajashree and Hashem, Rswl Mahmoud and Bainsal, Neeraj},
title = {Outsmarting Antigen Escape: Next‐Generation CAR T Cell Engineering Strategies for Durable Remissions in Hematologic Malignancies},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70252}
}
EUVIMED